Anaplastic Lymphoma Kinase Genomic Tumor Aberrations trials recruiting in New Hampshire

Fewer than 3 recruiting trials found.

All Anaplastic Lymphoma Kinase Genomic Tumor Aberrations trials nationally

Cities in New Hampshire

Recruiting trials in New Hampshire

• A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
  NCT06362369 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New Hampshire: Lebanon